VRTX · News · 20260814N
Guidance / Outlook
VERTEX PHARMACEUTICALS INC / MA · 2026-08-14 · Importance 75 · Surprise 60 · In source text
Vertex raised its full-year 2026 revenue guidance to $13.1 billion-$13.2 billion. The revised outlook reflects stronger reported performance during 2026. The updated range implies continued annual revenue growth from the company’s commercial portfolio.
Key facts
- Vertex raised its full-year 2026 revenue guidance to US$13.1 billion to US$13.2 billion. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Vertex raised its full-year 2026 revenue guidance to US$13.1 billion to US$13.2 billion. |